Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Phase I/Ib trial of combined 5’azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumours
Protocol ID
OZM-077 (COZMOS)
Disease (Sub Disease)
Brain and Spinal Tumours (Ependymoma)
Diagnosis Stage
Relapse/ refractory
Location
NSW, QLD, VIC, WA, SA
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
The Hospital for Sick Children
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 year to 18 years
International registry ID's
NCT03206021
Back to Registry
Study Title Phase I/Ib trial of combined 5’azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumours
Protocol ID OZM-077 (COZMOS)
Disease (Sub Disease) Brain and Spinal Tumours (Ependymoma)
Diagnosis Stage Relapse/ refractory
Location NSW / QLD / VIC / WA / SA
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ The Hospital for Sick Children
Links https://clinicaltrials.gov/ct2/show/NCT03206021
Trial Status Open
Trial Open Date 01/09/2019
Sites The Children's Hospital at Westmead / John Hunter Children's Hospital / Monash Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital
Study Type Treatment
Phase Phase 1
Age Eligibility 1 year to 18 years
International registry ID's NCT03206021